Search - tctmd.com

Displaying 1 - 13 of 13

Sort: Relevancy | Date

News Opinion Editor's Corner TCT 2024

What’s Going to Be Big at TCT 2024?

Michael O'Riordan

October 17, 2024

Presentation TCT 2023

TCT 945: Conform WhenThings are Unconformable: Novel Utilization of Combined Thrombectomy Devices to remove a Massive Organized Clot-in-Transit

Presenter: Mohammad Akram Kawsara

October 25, 2023

Presentation TCT 2023

TCT 944: Sucessful Aspiration of Saddle Pulmonary Embolism and Thrombus in Transit via PFO

Presenter: Mouzam Faroqui

October 25, 2023

News Conference News TCT 2022

FLASH: More Data to Support Mechanical Thrombectomy in PE

L.A. McKeown

September 18, 2022

News Conference News TCT 2022

New Faces, New Formats, New Tech: What to Expect From TCT 2022

Shelley Wood

September 07, 2022

News Conference News TCT 2021

Failed MitraClip Is Uncommon, but Bleak When It Happens

Michael O'Riordan

October 08, 2021

News Conference News TCT 2020

Encouraging Results Seen for TAVR in Failed Surgical or TAVR Valves

Todd Neale

October 17, 2020

Presentation TCT 2020

TRANSIT: Treatment of Failed TAVR With TAVR

Presenter: Luca Testa

October 17, 2020

News Opinion Editor's Corner TCT 2020

TCT 2020: Short DAPT, Longer TAVR Outcomes, Intravascular Imaging, and More

Shelley Wood

October 09, 2020

Presentation TCT 2016

TMVR Clinical Trial Design: Early Insights from Industry

Presenter: Charles J. Davidson, Nicole Ibrahim, Dan Mans

October 30, 2016

Presentation TCT 2016

TMVR Clinical Trial Design: Similarities and Differences -TAVR and Transcatheter Mitral Therapy Clinical Trials

Presenter: Charles J. Davidson, Nicole Ibrahim, Paul Sorajja

October 30, 2016

Presentation TCT 2016

FDA Perspectives

Presenter: Charles J. Davidson, Nicole Ibrahim, John C Laschinger

October 30, 2016

Presentation TCT 2012

The Mitochondrial Permeability Transition Pore is a Target for Pharmacological Cardioprotection in Human Hypertrophic Cardiomyopathy

Presenter: Paul S. Rees, Sean M. Davidson, Sian E. Harding, Perry M. Elliott, Derek J. Hausenloy, Derek M. Yellon

January 03, 2012

Advertisement

What’s Going to Be Big at TCT 2024?

TCT 945: Conform WhenThings are Unconformable: Novel Utilization of Combined Thrombectomy Devices to remove a Massive Organized Clot-in-Transit

TCT 944: Sucessful Aspiration of Saddle Pulmonary Embolism and Thrombus in Transit via PFO

FLASH: More Data to Support Mechanical Thrombectomy in PE

New Faces, New Formats, New Tech: What to Expect From TCT 2022

Failed MitraClip Is Uncommon, but Bleak When It Happens

Encouraging Results Seen for TAVR in Failed Surgical or TAVR Valves

TRANSIT: Treatment of Failed TAVR With TAVR

TCT 2020: Short DAPT, Longer TAVR Outcomes, Intravascular Imaging, and More

TMVR Clinical Trial Design: Early Insights from Industry

TMVR Clinical Trial Design: Similarities and Differences -TAVR and Transcatheter Mitral Therapy Clinical Trials

FDA Perspectives

The Mitochondrial Permeability Transition Pore is a Target for Pharmacological Cardioprotection in Human Hypertrophic Cardiomyopathy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content